search icon
pali-img

Palisade Bio Inc, Common Stock

PALI

NAQ

$0.807

+$0.05

(6.61%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.43M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
87.55K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.33
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.6 L
$5.38 H
$0.807

About Palisade Bio Inc, Common Stock

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePALISectorS&P500
1-Week Return17.5%-1.91%-1.87%
1-Month Return14.05%-3.82%8.93%
3-Month Return-14.74%-11.56%-2.39%
6-Month Return-66.38%-10.21%-2.41%
1-Year Return-84.36%-9.91%10.88%
3-Year Return-99.8%-0.28%46.93%
5-Year Return-99.98%31.29%94.89%
10-Year Return-100%75.9%177.5%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue13.52K-250.00K250.00K-[{"date":"2020-12-31","value":5.41,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue146.00K168.00K167.00K4.00K-[{"date":"2020-12-31","value":86.9,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.4,"profit":true},{"date":"2023-12-31","value":2.38,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(132.48K)(168.00K)(167.00K)250.00K-[{"date":"2020-12-31","value":-52.99,"profit":false},{"date":"2021-12-31","value":-67.2,"profit":false},{"date":"2022-12-31","value":-66.8,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin(979.88%)-(66.80%)100.00%-[{"date":"2020-12-31","value":-979.88,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-66.8,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses9.30M41.85M15.31M13.32M14.86M[{"date":"2020-12-31","value":22.21,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":36.58,"profit":true},{"date":"2023-12-31","value":31.82,"profit":true},{"date":"2024-12-31","value":35.5,"profit":true}]
Operating Income(9.30M)(41.85M)(15.72M)(13.07M)(14.86M)[{"date":"2020-12-31","value":-929700000,"profit":false},{"date":"2021-12-31","value":-4185400000,"profit":false},{"date":"2022-12-31","value":-1572100000,"profit":false},{"date":"2023-12-31","value":-1307000000,"profit":false},{"date":"2024-12-31","value":-1485900000,"profit":false}]
Total Non-Operating Income/Expense(2.10M)12.15M1.45M755.00K409.00K[{"date":"2020-12-31","value":-17.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":11.91,"profit":true},{"date":"2023-12-31","value":6.21,"profit":true},{"date":"2024-12-31","value":3.37,"profit":true}]
Pre-Tax Income(10.32M)(26.62M)(14.26M)(12.30M)(14.44M)[{"date":"2020-12-31","value":-1032200000,"profit":false},{"date":"2021-12-31","value":-2661600000,"profit":false},{"date":"2022-12-31","value":-1426000000,"profit":false},{"date":"2023-12-31","value":-1230000000,"profit":false},{"date":"2024-12-31","value":-1443800000,"profit":false}]
Income Taxes248.00K655.00K(1.46M)16.00K-[{"date":"2020-12-31","value":37.86,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-223.05,"profit":false},{"date":"2023-12-31","value":2.44,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(10.57M)(27.27M)(12.80M)(12.32M)-[{"date":"2020-12-31","value":-1057000000,"profit":false},{"date":"2021-12-31","value":-2727100000,"profit":false},{"date":"2022-12-31","value":-1279900000,"profit":false},{"date":"2023-12-31","value":-1231600000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(10.32M)(26.62M)(14.26M)(12.30M)(14.44M)[{"date":"2020-12-31","value":-1032200000,"profit":false},{"date":"2021-12-31","value":-2661600000,"profit":false},{"date":"2022-12-31","value":-1426000000,"profit":false},{"date":"2023-12-31","value":-1230000000,"profit":false},{"date":"2024-12-31","value":-1443800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(10.57M)(27.27M)(12.80M)(12.30M)(14.44M)[{"date":"2020-12-31","value":-1057000000,"profit":false},{"date":"2021-12-31","value":-2727100000,"profit":false},{"date":"2022-12-31","value":-1279900000,"profit":false},{"date":"2023-12-31","value":-1230000000,"profit":false},{"date":"2024-12-31","value":-1443800000,"profit":false}]
EPS (Diluted)(13.42)17.08(16.53)(7.96)(10.92)[{"date":"2020-12-31","value":-78.57,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-96.78,"profit":false},{"date":"2023-12-31","value":-46.6,"profit":false},{"date":"2024-12-31","value":-63.96,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PALI
Cash Ratio 2.60
Current Ratio 2.84

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PALI
ROA (LTM) -74.50%
ROE (LTM) -153.55%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PALI
Debt Ratio Lower is generally better. Negative is bad. 0.35
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.65

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PALI
Trailing PE NM
Forward PE NM
P/S (TTM) 14.03
P/B 0.71
Price/FCF NM
EV/R 234.89
EV/Ebitda 0.57

FAQs

What is Palisade Bio Inc share price today?

Palisade Bio Inc (PALI) share price today is $0.807

Can Indians buy Palisade Bio Inc shares?

Yes, Indians can buy shares of Palisade Bio Inc (PALI) on Vested. To buy Palisade Bio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PALI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Palisade Bio Inc be purchased?

Yes, you can purchase fractional shares of Palisade Bio Inc (PALI) via the Vested app. You can start investing in Palisade Bio Inc (PALI) with a minimum investment of $1.

How to invest in Palisade Bio Inc shares from India?

You can invest in shares of Palisade Bio Inc (PALI) via Vested in three simple steps:

  • Click on Sign Up or Invest in PALI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Palisade Bio Inc shares
What is Palisade Bio Inc 52-week high and low stock price?

The 52-week high price of Palisade Bio Inc (PALI) is $5.38. The 52-week low price of Palisade Bio Inc (PALI) is $0.6.

What is Palisade Bio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Palisade Bio Inc (PALI) is 0.71

What is the Market Cap of Palisade Bio Inc?

The market capitalization of Palisade Bio Inc (PALI) is $3.43M

What is Palisade Bio Inc’s stock symbol?

The stock symbol (or ticker) of Palisade Bio Inc is PALI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top